Cynata wins EU ethics approval for phase 2 Trial of CYP-001
Biotech company Cynata Therapeutics (ASX:CYP) received regulatory and ethics approval in the…
Cynata Therapeutics Limited (ASX:CYP)
About Cynata Therapeutics Limited
Key Information
CYP In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 17/04/2024 | Notification regarding unquoted securities - CYP | 18.39KB | 914 |
| 08/04/2024 | Price Sensitive PS DFU Clinical Trial Enrolment Complete | 141.17KB | 5.2K |
| 20/03/2024 | Price Sensitive PS EU Approval for Phase 2 CYP-001 Trial in GvHD | 151.52KB | 1.4K |
| 18/03/2024 | Cynata Presenting at Advanced Therapies Congress | 2.84MB | 351 |
| 05/03/2024 | Price Sensitive PS First Patient Treated in Phase 2 GvHD Trial | 154.43KB | 10K |
| 29/02/2024 | Cynata Appoints New Chief Business Officer | 157.89KB | 2.0K |
| 26/02/2024 | Price Sensitive PS Encouraging Initial Data from CYP-006TK DFU Trial | 161.15KB | 9.8K |
| 23/02/2024 | Price Sensitive PS Appendix 4D & Half-Year Financial Statements | 828KB | 642 |